Warning: include() [function.include]: URL file-access is disabled in the server configuration in /home/antinode/public_html/wp-content/themes/wp-medical-doctor/sidebar.php on line 67

Warning: include(http://www.linkworth.com/act/partner/code/linkad_ads.php?web_id=50291&loc_id=1&pla_id=91825&link_format=6&hash=5acb1640bc0fe77ecb396679deed017b) [function.include]: failed to open stream: no suitable wrapper could be found in /home/antinode/public_html/wp-content/themes/wp-medical-doctor/sidebar.php on line 67

Warning: include() [function.include]: Failed opening 'http://www.linkworth.com/act/partner/code/linkad_ads.php?web_id=50291&loc_id=1&pla_id=91825&link_format=6&hash=5acb1640bc0fe77ecb396679deed017b' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/antinode/public_html/wp-content/themes/wp-medical-doctor/sidebar.php on line 67

Final Hospital Vote Set For Feb. 3

“We have looked at this and looked at this and looked at this,” said Supervisor
(D-Sugarland Run). “It’s time to vote. It’s time to take action.”
The unanimous decision to schedule a vote came after the Board of Supervisors, meeting as a committee of the whole, spent more than two hours questioning county staff members and representatives of HCA Virginia, the company that wants to build the hospital. They asked, among other questions, whether Read the rest of this entry »

IMPAX Receives Final FDA Approval for Omeprazole 40 mg Capsules

IMPAX Laboratories, Inc.
(OTC: IPXL), through its generic drug
division Global Pharmaceuticals, announced that yesterday the U.S. Food
and Drug Administration (FDA) granted final approval of the Company’s
Abbreviated New Drug Application (ANDA) for a generic version of
Prilosec 40 mg Delayed-release Capsules. AstraZeneca markets Prilosec
for the treatment of duodenal/gastric ulcers and GERD (gastro-esophageal
reflux disease).
The Company’s versions Read the rest of this entry »

Allos Therapeutics Final Results on Lymphoma Drug Pralatrexate

(RTTNews) - 
Biopharmaceutical company Allos Therapeutics, Inc. (ALTH:
) Tuesday said that the final results of the study on lymphoma drug pralatrexate revealed that the median duration of response exceeded 9 months with 27% response rate, a key secondary endpoint of the trial. Based on these results, the company said it plans to submit a New Drug Application, or NDA, to the FDA in the first half of 2009, seeking Read the rest of this entry »

Allos Therapeutics Announces Final Results from Pivotal PROPEL

Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced final results
from the Company’s pivotal Phase 2 PROPEL trial of pralatrexate in
patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
PTCL comprises a biologically diverse group of blood cancers that
account for approximately 10% to 15% of all cases of non-Hodgkin’s
lymphoma (NHL) in the United States.
As previously reported, 29 of 109 evaluable patients, or 27%, achieved Read the rest of this entry »

The Children's Hospital of Philadelphia Erects the Final Beam of

“Our goal is to advance the health of children by turning scientific discovery into medical innovation,” said Philip R. Johnson, M.D., chief scientific officer at Children’s Hospital. “This state-of-the-art facility enables Children’s Hospital to recruit top-level researchers by providing the space, equipment and technology required to advance pediatric medicine. Children’s Hospital will be poised to be the preeminent institution conducting translational Read the rest of this entry »

US Department of Labor final rule will expand FMLA for military

The Ragsdale Decision/Penalties: The updated rule contains technical changes to be consistent with the U.S. Supreme Court’s decision in Ragsdale v. Wolverine World Wide Inc. The court ruled that the regulation’s so-called “categorical” penalty (requiring an employer to provide 12 additional weeks of FMLA-protected leave after the employee had already taken 30 weeks of leave) was inconsistent with the statutory limit of only 12 weeks of FMLA leave Read the rest of this entry »

Cranial Implant Process in Final Stages of FDA Approval

Kelyniam Global, Inc. (PINKSHEETS: KLYG),
an advanced Engineering and Rapid Prototyping Company specializing in the
use of CADCAM technology, today announced that the Bio-CADCAM cranial
implant process their medical suppliers use is in final stages of FDA
approval.
Over the last several months, Kelyniam Global has been contracted by, and
working closely with a major medical supplier in the development of
artificial replacement implants for the human Read the rest of this entry »

Creamer out of hospital, will play ADT final round

Creamer out of hospital, will play ADT final round
WEST PALM BEACH, Fla. (AP) — Paula Creamer was cleared by doctors to play the final round of the LPGA Tour’s season-ending ADT Championship on Sunday morning, keeping alive her hopes of winning the yearlong money title.
Creamer was admitted to Bethesda Memorial Hospital in Boynton Beach, Fla., on Saturday night, after enduring abdominal pain for three days.
She arrived at Trump International Read the rest of this entry »

Lewes Steps Out for Fitness to present final awards tonight

The Lewes Steps Out For Fitness committee invites the entire community to welcome fall to Delaware’s Cape Region with a beach bonfire celebration and final awards ceremony on Lewes Beach.
Starting at 6 p.m. Thursday, Sept. 18, the evening’s events will include a massive bonfire constructed by Lewes blacksmith John Ellsworth, demonstrations by the Lewes Fire Department aerial truck and crew, music by Lewes Police Department detective Read the rest of this entry »

Final House Vote on SCHIP Delivers Peace of Mind to America's Families

1.5 million uninsured Hispanic children will receive coverage
,
Feb. 4
/PRNewswire-USNewswire/ — “This afternoon, Congress put America’s families first on their agenda by reauthorizing the State Children’s Health Insurance Program (SCHIP). Today’s final vote in the House of Representatives delivers critical help to modest-income families struggling to make ends meet in challenging financial times,” said Dr.
Jane L. Delgado
, President Read the rest of this entry »